The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback